Evidence map›Paper›PMID 39829776›Full record

ArticlebioRxiv : the preprint server for biology2025

Optogenetic control of Protein Kinase C-epsilon activity reveals its intrinsic signaling properties with spatiotemporal resolution.

Qunxiang Ong, Crystal Jing Yi Lim, Yilie Liao, Justin Tze-Yang Ng, Ler Ting Rachel Lim, Shernys Xuan Yi Koh, Sher En Chan, Pheobe Lee Yu Ying, Huijun Lim, Chen Rui Ye and 7 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Qunxiang OngLaboratory of Metabolic Medicine, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore.ORCID 0000-0003-3674-2105
Crystal Jing Yi LimLaboratory of Metabolic Medicine, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore.
Yilie LiaoLaboratory of Metabolic Medicine, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore.
Justin Tze-Yang NgBioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Ler Ting Rachel LimLaboratory of Metabolic Medicine, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore.
Shernys Xuan Yi KohLaboratory of Metabolic Medicine, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore.
Sher En ChanLaboratory of Metabolic Medicine, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore.
Pheobe Lee Yu YingLaboratory of Metabolic Medicine, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore.
Huijun LimLaboratory of Metabolic Medicine, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore.
Chen Rui YeLaboratory of Metabolic Medicine, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore.
Loo Chien WangFunctional Proteomics Laboratory, SingMass National Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore.
Siok Ghee LerFunctional Proteomics Laboratory, SingMass National Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore.
Radoslaw M SobotaFunctional Proteomics Laboratory, SingMass National Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore.
Yaw Sing TanBioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Gerald I ShulmanDepartments of Internal Medicine and Cellular & Molecular Physiology, Yale School of Medicine, New Haven, CT 06520, Howard Hughes Medical Institute, Chevy Chase, MD.
Xiaoyong YangDepartments of Comparative Medicine and Cellular & Molecular Physiology, Yale School of Medicine, New Haven, CT 06520.
Weiping HanLaboratory of Metabolic Medicine, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore.

Funding

Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI GERALD I SHULMAN · 1993 to 2026
$44.0M
O-GlcNAc Modification in Metabolic HomeostasisR01DK089098 · NIDDK · YALE UNIVERSITY · PI YANG, XIAOYONG · 2010 to 2021
$3.0M
Body weight control by hypothalamic OGTR01DK137467 · NIDDK · YALE UNIVERSITY · PI Xiaoyong Yang · 2023 to 2026
$2.7M
Mechanism of Renal Cortical Insulin ResistanceR01DK133143 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2022 to 2025
$2.3M
O-GlcNAc Signaling in Central Control of Energy BalanceR01DK102648 · NIDDK · YALE UNIVERSITY · PI YANG, XIAOYONG · 2016 to 2019
$1.8M
NIDDK NIH HHS P30 DK045735NIDDK NIH HHS R01 DK089098NIDDK NIH HHS R01 DK102648NIDDK NIH HHS R01 DK133143NIDDK NIH HHS R01 DK137467
6 · The paper itself

Abstract

The regulation of PKC epsilon (PKCε) and its downstream effects is still not fully understood, making it challenging to develop targeted therapies or interventions. A more precise tool that enables spatiotemporal control of PKCε activity is thus required. Here, we describe a photo-activatable optogenetic PKCε probe (Opto-PKCε) consisting of an engineered PKCε catalytic domain and a blue-light inducible dimerization domain. Molecular dynamics and AlphaFold simulations enable rationalization of the dark-light activity of the optogenetic probe. We first characterize the binding partners of Opto-PKCε, which are similar to those of PKCε. Subsequent validation of the Opto-PKCε tool is performed with phosphoproteome analysis, which reveals that only PKCε substrates are phosphorylated upon light activation. Opto-PKCε could be engineered for recruitment to specific subcellular locations. Activation of Opto-PKCε in isolated hepatocytes reveals its sustained activation at the plasma membrane is required for its phosphorylation of the insulin receptor at Thr1160. In addition, Opto-PKCε recruitment to the mitochondria results in its lowering of the spare respiratory capacity through phosphorylation of complex I NDUFS4. These results demonstrate that Opto-PKCε may have broad applications for the studies of PKCε signaling with high specificity and spatiotemporal resolution.

Indexed as

insulin resistanceOptogeneticsphosphoproteomicsProtein Kinase C-epsilonsignaling dissectionsubcellular resolution

Identifiers

PMID39829776
PMCPMC11741287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.